ALTSTATION.IO

Globe Life Inc. (GL) Stock Analysis

By Nova Skye | AltStation.io | Updated September 13, 2026

Price
$170.96
Change
+0.09%
Market Cap
$13.14B
Avg Volume
611.5K

Company Overview

Globe Life Inc. is an insurer headquartered in McKinney, Texas, operating within the life insurance branch of the financial services sector. The company sells straightforward coverage, including term, whole, and children’s life policies, alongside supplemental health plans covering cancer, heart conditions, accidents, and hospital stays. Their target customer base is strictly lower-middle and middle-income families across the United States. Distribution runs across four clear routes: direct-to-consumer channels, exclusive independent agents, general agency independent agents, and brokers.

Globe Life operates as a specialized niche player rather than a sprawling financial conglomerate. Their core edge is direct access to middle-income households that large diversified insurers routinely overlook, paired with a dedicated agent sales force. The downside to this focus is product concentration, as relying heavily on supplemental health and final expense coverage leaves them sensitive to consumer spending pullbacks. They win on simplicity and direct distribution, but they face constant pressure from standard life insurers competing for the same demographic.

Founded in 1900, the company has over 120 years of operating history and executed a major identity shift in August 2019 by changing its name from Torchmark Corporation to Globe Life Inc. The business currently operates across three core segments: Life Insurance, Supplemental Health Insurance, and Investments. They are not pivoting into speculative fintech models; they remain committed to traditional policy underwriting and cash collection. The bottom line comes down to steady execution across their agent networks and investment yield across those three distinct segments.

Key Financials
Market Cap
$13.14B
Revenue
$6.19B
EBITDA
$1.68B
Gross Margin
33.9%
Profit Margin
19.6%
Revenue Growth
8.0%
Total Cash
$455.38M
Total Debt
$3.43B
Free Cash Flow
$1.16B


52-Week Price Performance Analysis

Price Statistics
P/E Ratio
11.36
Forward P/E
10.35
Beta
0.46
52-Week High
$191.55
52-Week Low
$127.85
EPS
$15.05
50-Day Avg
$177.99
200-Day Avg
$154.57
Price/Book
2.14
GL 52-Week Stock Chart
Technical Analysis
GL trades at $170.96, 68% of the way from its $127.07 52-week low to its $191.55 high. The stock is 10.64% below that high but remains 34.71% above the low. Near-term momentum is weak, with declines of 3.03% over five trading days and 5.26% over 20 trading days. Price is 1.42% below the 20-day moving average of $173.63. Support sits at the 30-day low of $169.82, while resistance is the 30-day high of $186.02.


Recent News and Developments

Amundi boosts Globe Life stake 307.4%

Amundi bought 122,402 Globe Life shares during the second quarter, lifting its position to 162,223 shares. The holding was valued at $28.986 million in its latest SEC filing. Source: MarketBeat

HighTower raises Globe Life position 78.1%

HighTower Advisors acquired 8,690 Globe Life shares during the second quarter. It finished the period with 19,813 shares valued at $3.54 million. Source: MarketBeat

Squarepoint increases Globe Life stake 79%

Squarepoint Ops purchased 24,575 Globe Life shares during the second quarter, bringing its position to 55,676 shares. The stake was valued at $9.948 million in its latest filing. Source: MarketBeat



Market Sentiment and Analyst Recommendations

Bull Case
Globe Life generated $6.19 billion in revenue, with revenue growth of 8.0%. That growth paired with a P/E of 11.36 makes the valuation attractive. The $193.91 analyst target implies $22.95 of upside from the current $170.96 price. All 11 analysts collectively rate the stock a buy, with the highest target reaching $225.00. Institutional buying has also been strong: Amundi increased its stake 307.4%, HighTower raised its position 78.1%, and Squarepoint added 79%. The bull case is straightforward: GL offers positive revenue growth, a low earnings multiple, and analyst-backed upside while trading 10.64% below its 52-week high.
Bear Case
The stock’s short-term trend is clearly negative, down 3.03% over five trading days and 5.26% over 20 trading days. At $170.96, GL is only $1.14 above its $169.82 near-term support. A break below that level would weaken an already soft technical setup. Total debt of $3.43 billion is more than seven times the company’s $455.38 million in cash, leaving limited balance-sheet flexibility. Analyst expectations are not uniformly bullish because the low target of $166.00 sits below the current price. Institutional activity is mixed as well: Carmignac Gestion cut its stake by 37%, selling 62,900 shares and retaining 107,100 shares.
What to Watch
The first level to monitor next quarter is $169.82, the 30-day low and immediate support. A sustained move back above the $173.63 20-day moving average would be the first sign that the 5.26% 20-day decline is stabilizing. The stronger technical test is $186.02, the 30-day high and current resistance. Investors should also track whether revenue growth holds at 8.0% and whether the P/E remains near 11.36. Institutional filings matter after September’s mixed signals: Amundi, HighTower, and Squarepoint added shares, while Carmignac sold 62,900 shares. The thesis strengthens above $186.02 with sustained revenue growth, but a drop below $169.82 combined with weaker growth would make the bear case more convincing.
Analyst Consensus
BUY

Based on 11 analyst opinions
Low Target
$166.00
Mean Target
$193.91
High Target
$225.00


Earnings and Financial Data

Sector
Financial Services
Industry
Insurance – Life
Employees
3,695
Earnings & Dividends
Next Earnings
Oct 21, 2026
EPS (Trailing)
$15.05
Dividend Yield
77.0%
Payout Ratio
8.0%

Frequently Asked Questions

Is GL a good stock to buy?
GL has a buy recommendation from 11 analysts, revenue growth of 8.0%, and a P/E of 11.36. The takeaway is that the fundamental setup looks attractive, but near-term momentum is weak.
What is GL’s analyst price target?
The analyst target is $193.91, with estimates ranging from $166.00 to $225.00. The takeaway is that the consensus target sits above the current $170.96 price, although the lowest target implies downside.
How far is GL below its 52-week high?
GL is 10.64% below its $191.55 52-week high and 34.71% above its $127.07 technical low. The takeaway is that the stock remains well above its low but has not recovered its peak.
What are GL’s support and resistance levels?
Near-term support is $169.82, while near-term resistance is $186.02. The takeaway is that GL is trading close to support at its current price of $170.96.
Is GL stock currently showing positive momentum?
No. GL is down 3.03% over five trading days, down 5.26% over 20 trading days, and trades 1.42% below its $173.63 20-day moving average. The takeaway is that short-term momentum remains bearish.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated September 13, 2026.